Acurian shortens timelines by up to 20 months for a Uterine Fibroid program

This was an important phase III, two-protocol study for a first-in-class treatment of abdominal uterine bleeding in women with uterine fibroids.

The sponsor was facing significant enrollment challenges. Site start-up was delayed; sites were unable to meet their overly optimistic commitments to deliver enough patients; many patients were unwilling to wash off their current birth control medications to participate…

Women’s Health

Acurian keeps women-focused clinical trials healthy and productive.

We’ve supported a variety of trials for conditions affecting women, including endometriosis, vasomotor symptoms in menopause, vaginal atrophy, and fibromyalgia. Our industry-leading expertise with patient enrollment and retention can help you generate quality data with faster trial completion and more budget control.

Acurian has recruited and enrolled thousands of patients for more than 60 pharmaceutical and biotech companies representing over 4,500 research sites.